PYRAFAT

This brand name is authorized in Austria, Estonia, Germany, Hong Kong SAR China, Lithuania, Malta.

Active ingredients

The drug PYRAFAT contains one active pharmaceutical ingredient (API):

1	Pyrazinamide UNII 2KNI5N06TI - PYRAZINAMIDE
	Pyrazinamide exhibits tuberculostatic activity. Pyrazinamide is active only at an acid pH, and it is therefore active mainly on the tubercle bacilli located within the cell.
	Read more about Pyrazinamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J04AK01	Pyrazinamide	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AK Other drugs for treatment of tuberculosis
Discover more medicines within J04AK01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07568413, 07568436
EE	Ravimiamet	1180189
HK	Department of Health Drug Office	34750
LT	Valstybinė vaistų kontrolės tarnyba	1001644, 1016285
MT	Medicines Authority	AA729/24901